Keep the Hydroxychloroquine! SLICC cohort eval flare risk in 1460 pts who⬇️or d/c HCQ: 👉pts in remission who d/c HCQ flared HR 2.77 (1.46,5.26) 👉pts in remission who⬇️dose flared HR 2.14 (1.34, 3.42) Abst#0959 #Plenary #ACR21 @rheumnow #ACRbest https://t.co/92U215s8IP